FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/034806 [Registered on: 13/07/2021] Trial Registered Prospectively
Last Modified On: 06/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effect of two drugs, Fentanyl and Buprenorphine as an adjuvant to Bupivacaine in spinal anaesthesia for Lower Segment Cesarean Section 
Scientific Title of Study   Randomized double blind control trial between intrathecal Buprenorphine and intrathecal Fentanyl as an adjuvant to Bupivacaine in spinal anaesthesia for lower segment caesarean section 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr PATEL NELKA MUKESHKUMAR 
Designation  Junior resident academic 
Affiliation  Bharati Vidyapeeth (Deemed to be University) medical college and research center, Pune 
Address  Department of Anaesthesia Bharati Vidyapeeth (Deemed to be University) medical college and research center, Dhankawadi, Pune

Pune
MAHARASHTRA
411043
India 
Phone  8128658765  
Fax    
Email  patelnelkam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr POOJA NARAYAN BHOSLE 
Designation  Associat Professor 
Affiliation  Bharati Vidyapeeth (Deemed to be University) medical college amd research center, Pune 
Address  Department of Anaesthesia, Bharati Vidyapeeth (Deemed to be University) medical college and research center,Dhankawadi, pune

Pune
MAHARASHTRA
411043
India 
Phone  9860835279  
Fax    
Email  bhosle_pooja@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr POOJA NARAYAN BHOSLE 
Designation  Associat Professor 
Affiliation  Bharati Vidyapeeth (Deemed to be University) medical college amd research center, Pune 
Address  Department of Anaesthesia, Bharati Vidyapeeth (Deemed to be University) medical college and research center,Dhankawadi, pune

Pune
MAHARASHTRA
411043
India 
Phone  9860835279  
Fax    
Email  bhosle_pooja@yahoo.co.in  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth (Deemed to be) medical College and research center, Pune 
 
Primary Sponsor  
Name  Bharati Vidyapeeth Deemed to be University medical college and research center 
Address  Bharati Vidyapeeth (Deemed to be University) Medical college and research center, pune 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPATEL NELKA MUKESHKUMAR  Bharati Vidyapeeth (Deemed to be) medical college and research center, Pune  Department of Anaesthesia, Bharati Vidyapeeth medical college and research center, Pune
Pune
MAHARASHTRA 
8128658765

patelnelkam@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati Vidyapeeth ( Deemed to be University) medical college, pune, institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Buprenorphine  Inj Buprenorphine 60mcg+ Inj Bupivacaine Heavy 5% 1.8ml 
Intervention  Fentanyl  Inj Fentanyl 25mcg+ Inj Bupivacaine heavy 5% 1.8ml 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ASA II 
 
ExclusionCriteria 
Details  •ASA III/IV/V
•Patients with comorbidites during pregnancy- gestational diabetes mellitus, pregnancy induce hypertension, heart disease
•Contraindications of spinal anaesthesia- raised intracranial pressure, local infection, coagulation disorders 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
•post Operative regain of sensory block and motor block
•post operative duration of first rescue analgesia demand 
Observation of motor and sensory block after spinal anaesthesia in lower segment caesarean section every 5 minutes upto 10 minutes then every 10 minutes upto end of surgery  
 
Secondary Outcome  
Outcome  TimePoints 
Hemodynamic stability after giving spinal anaesthesia in lower segment caesarean section  Heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, oxygen saturation for every 5 min for 10 minutes then every 10 minutes upto end of surgery 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study is randomized, double blind, trial Comparing the efficacy between intrathecal buprenorphine and Fentanyl as an adjuvant to bupivacaine in spinal anaesthesia in Lower Segment Cesarean Section for duration of sensory and motor block for surgery and duration of 1st rescue analgesia in post operative period and number of analgesic requirements in 24 hours postoperatively.

 
Close